Berkshire Hathaway has resumed acquiring shares of Warren Buffett's favorite media stock. Other insider buyers are focused on ...

GAAP revenue was $47.2 million, missing analyst estimates of $47.24 million. Vafseo, its oral anemia drug for dialysis patients, saw GAAP net product revenue of $13.3 million as prescriber access and ...